Steam power: could vapor ablation offer a new way to stop heavy periods?
NCT ID NCT07580560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tested a new device that uses vapor (steam) to destroy the lining of the uterus in 10 premenopausal women with heavy menstrual bleeding who no longer want children. The goal was to see if the procedure is safe. If successful, it could provide a less invasive alternative to hysterectomy for controlling abnormal uterine bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Aqua Therapeutics Thermal Therapy Vapor Ablation System (ATTTVAS) – a device that uses vapor to destroy the uterine lining
What this could lead to
If it works, this could offer a less invasive, outpatient option for women with heavy bleeding who are done having children, potentially avoiding more major surgery.
What could go wrong
This is a very early, first-in-human pilot study with only 10 participants. The device may not be safe or effective in larger groups, and vapor ablation is a new technique with unknown long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Milano
Milan, Italy
-
Roma
Roma, Italy
-
Veldhoven
Veldhoven, Netherlands